WinstonWınston
Profile Solutions logo

Profile Solutions

PSIQ
23
Drug Manufacturers - Specialty & Generic · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$38,829
Winston Score
23
Winston is worried
Weak fundamentals across most pillars.
Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.

Share count rising — dilution

+28.7% over 3y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 600.0M (2015) → 771.9M (2018)

Profile Solutions, Inc. is a small specialty pharmaceutical company focused on developing and commercializing drug products, primarily in areas like pain management and other therapeutic categories. The company works on formulating medications and bringing them to market, targeting patients and healthcare providers in the United States. It operates in the specialty and generic drug manufacturing industry, competing against both large pharmaceutical firms and other small development-stage companies.

The company generates revenue through product sales and licensing arrangements, though its operating margin of -58.4% signals it is spending significantly more than it earns right now. It is a micro-cap business with a market cap near zero, meaning it is very small and carries substantial financial risk. The deeply negative return on invested capital suggests the business has not yet found a sustainable path to profitability, and its main challenge going forward is whether it can grow revenue fast enough to cover its operating costs before running low on cash.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

81.7%ownership

Flat

Insiders holding steady — not selling despite ability to

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
55.3%
no trend
Premium pricing power — 55.3% gross margin
Operating Margin
-58.4%
no trend
Losing money on operations — -58.4%
ROCE
-104.2%
no trend
Weak — -104.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+320.9%
no trend
Fast-growing sales (320.9% YoY)
EPS YoY
N/A
no trend
Data not available
EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
no trend
Data not available
FCF Margin
-73.7%
no trend
Burning cash (-73.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.01
no trend
Conservative — low debt load (0.01)
Interest Cover
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial